Galen Partners closes fourth fund on $250m

The New York-based firm, which provides expansion-stage capital to healthcare companies, fell short of its original $300 million target.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this